Faster Maze Completion After CBD: Learning, Movement and Female Alzheimer-Model Mice

forensic toxicology working group members October 28, 2026 Forensic Toxicology

Long-term CBD shortened reward-finding times in female Alzheimer-model mice, but also changed their movement speed. That makes a simple claim of improved memory incomplete: speed, acquisition and later recall need separate examination.

An eight-month prevention experiment

Female APPxPS1 and wild-type-like mice received CBD or vehicle in oral gel pellets beginning at 2.5 months of age. The CBD regimen was 20 mg/kg daily for eight months. Testing included a food-reward cheeseboard task, fear conditioning and anxiety-related behavior.

Treatment began well before the final behavioral assessment. It was not a trial treating older human patients after a clinical dementia diagnosis.

Positive and null findings

CBD-treated APPxPS1 mice reached the reward more quickly during acquisition and moved faster early in training. The authors described moderate learning-related benefit while acknowledging locomotor changes. CBD did not improve reversal learning or recall of previously rewarded locations.

The elevated-plus-maze findings included increased locomotion without a corresponding CBD effect on anxiety-like behavior. These distinctions prevent the result from becoming a general statement that CBD improved every cognitive or emotional outcome.

Why latency alone is insufficient

A shorter completion time can reflect better learning, faster movement, motivation or a combination. Evidence about memory becomes stronger when retention or location preference supports the same interpretation independently of travel speed.

The specific genotype, sex, prolonged exposure and preventive timing limit translation. A dose used in mice is not a human treatment recommendation. For evaluation of a claimed cannabis-related benefit, identify exactly which behavior improved, which measures did not and whether the intervention changed the mechanics of performing the test.